Medicus Pharma Ltd (MDCX)

May 05, 2025

Medicus Pharma to acquire Antev, advancing opportunity in prostate health solutions - Proactive Investors

May 05, 2025

May 01, 2025

Medicus Pharma to acquire Antev for $75M in share exchange transaction - MSN

May 01, 2025

Apr 29, 2025

Medicus Pharma signs letter of intent to buy British biotech company - The Business Journals

Apr 29, 2025

Apr 29, 2025

Medicus Pharma’s (MDCX) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Apr 29, 2025

Apr 28, 2025

Medicus Pharma to acquire Antev in strategic biotech deal By Investing.com - Investing.com South Africa

Apr 28, 2025

Apr 28, 2025

Medicus Pharma to acquire Antev in strategic biotech deal - Investing.com Australia

Apr 28, 2025

Apr 28, 2025

Small cap wrap: Medicus Pharma, Arizona Gold & Silver, Plug Power... - Proactive Investors

Apr 28, 2025

Apr 28, 2025

Market movers: Nvidia, Plug Power, Medicus Pharma... - Proactive financial news

Apr 28, 2025

Apr 28, 2025

Medicus Pharma Ltd To Acquire Antev Ltd. For $75 Million In A Share Exchange Transaction - marketscreener.com

Apr 28, 2025

Apr 28, 2025

Medicus Pharma to Acquire Antev Ltd. in $75 Million Deal - TipRanks

Apr 28, 2025

Apr 28, 2025

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction - Malay Mail

Apr 28, 2025

Apr 28, 2025

Medicus Pharma to acquire Antev, expanding pipeline with potentially first-in-class prostate treatment - Proactive financial news

Apr 28, 2025

Apr 22, 2025

Medicus Pharma Ltd’s Promising Clinical Developments and Strategic Expansion Drive Buy Rating - TipRanks

Apr 22, 2025

Apr 22, 2025

Medicus Pharma (NASDAQ:MDCX) Given Buy Rating at D. Boral Capital - Defense World

Apr 22, 2025

Apr 21, 2025

Medicus Pharma expands patient enrollment for skin cancer study By Investing.com - Investing.com Canada

Apr 21, 2025

Apr 21, 2025

Small cap wrap: Medicus Pharma, HIVE Digital Technologies, Spanish Mountain Gold... - Proactive Investors

Apr 21, 2025

Apr 21, 2025

Medicus Pharma expands basal cell carcinoma study after encouraging early data - Proactive financial news

Apr 21, 2025

Apr 21, 2025

Medicus Pharma Expands Phase 2 Study for Basal Cell Carcinoma Treatment - TipRanks

Apr 21, 2025

Apr 21, 2025

Medicus Pharma expands patient enrollment for skin cancer study - Investing.com

Apr 21, 2025

Apr 21, 2025

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC) - Newsfile

Apr 21, 2025

Apr 16, 2025

Medicus Pharma (CVE:MDC) Raised to Strong-Buy at D Boral Capital - Defense World

Apr 16, 2025

Apr 16, 2025

Medicus Pharma (NASDAQ:MDCX) Raised to Strong-Buy at D Boral Capital - Defense World

Apr 16, 2025

Apr 15, 2025

Medicus Pharma (NASDAQ:MDCX) Coverage Initiated by Analysts at D. Boral Capital - Defense World

Apr 15, 2025

Apr 14, 2025

Medicus Pharma initiated with a Buy at D. Boral Capital - TipRanks

Apr 14, 2025

Apr 14, 2025

Medicus Pharma Ltd. - FinancialContent

Apr 14, 2025

Apr 14, 2025

This Millrose Properties Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Apr 14, 2025

Apr 12, 2025

FY2025 EPS Estimate for Medicus Pharma Lifted by Analyst - Defense World

Apr 12, 2025

Apr 11, 2025

Brokers Set Expectations for Medicus Pharma Q1 Earnings - The AM Reporter

Apr 11, 2025

Apr 11, 2025

Research Analysts Issue Forecasts for Medicus Pharma Q1 Earnings - Defense World

Apr 11, 2025

Apr 11, 2025

Research Analysts Set Expectations for Medicus Pharma Q1 Earnings - Defense World

Apr 11, 2025

Apr 10, 2025

Medicus Pharma secures $15 million funding option - MSN

Apr 10, 2025

Apr 01, 2025

Will Medicus' D-MNA Prove To Be A Non-Invasive, Effective Alternative To Mohs Surgery For BCC? - RTTNews

Apr 01, 2025

Mar 28, 2025

Medicus Pharma Ltd. SEC 10-K Report - TradingView

Mar 28, 2025

Mar 28, 2025

Medicus Pharma Ltd. (MDCX) reports earnings - Quartz

Mar 28, 2025

Mar 27, 2025

Healthcare Disruptors: AI, Telehealth and Cost Savings - Value The Markets

Mar 27, 2025

Mar 27, 2025

ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out - WRAL.com

Mar 27, 2025

Mar 27, 2025

ValueTheMarkets Insights: Healthcare Climbs as Tech Stumbles in 2025 Shift - WRAL.com

Mar 27, 2025

Mar 27, 2025

While Big Pharma Stalls, One Small-Cap Breaks Out - TipRanks

Mar 27, 2025

Mar 26, 2025

Healthcare Climbs as Tech Stumbles in 2025 Shift - Value the Markets

Mar 26, 2025

Mar 25, 2025

Medicus Pharma cancels shareholder meeting notice By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Medicus Pharma cancels shareholder meeting notice - Investing.com

Mar 25, 2025

Mar 21, 2025

Pinpointing Hidden Stock Winners in a Volatile Market - Value The Markets

Mar 21, 2025

Mar 21, 2025

3 US Healthcare Stocks That Might Be Undervalued 2025 - Value The Markets

Mar 21, 2025

Mar 21, 2025

Medicus Pharma Share Price: MDCX Stock Closed Up 15.35%! - Value The Markets

Mar 21, 2025

Mar 20, 2025

Medicus Pharma announces annual meeting date - Investing.com

Mar 20, 2025

Mar 20, 2025

Medicus Pharma announces annual meeting date By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Advancing Oncology: Innovations in Treatment and Detection - Value The Markets

Mar 20, 2025

Mar 19, 2025

See Why Some Investors Are Watching This Biotech Company - Value The Markets

Mar 19, 2025

Mar 18, 2025

Biotech Stock Tapping $7B+ Skin Cancer Market Opportunity - Value The Markets

Mar 18, 2025

Mar 17, 2025

The Biotech Stocks Tackling the World’s Most Common Cancer - Value The Markets

Mar 17, 2025

Mar 11, 2025

Medicus Pharma - The Pharma Letter

Mar 11, 2025